Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and other diseases, today announced the publication online of Part 1 results from ...
DES MOINES (AP) -- Iowa's biotechnology base could spark new economic development opportunities in the state, a new study shows. The report from the Battelle Memorial Institute shows that scientific ...
A cohort study finds no significant differences in height among children with inflammatory diseases treated with JAK ...
SOUTH SAN FRANCISCO, Calif., March 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...
Unity Biotechnology, Inc. (NASDAQ:UBX) stock plummeted on Monday after the company released results from its latest study. The Phase 2b ASPIRE clinical trial of intravitreal UBX1325 involed patients ...
The grant will be used to underwrite the costs of a study ("Biotechnology Growth Strategy: N.C. Research Campus, Kannapolis and the Charlotte Region"). The study will focus on the potential economic ...
Sana Biotechnology reports six-month results from a first-in-human study demonstrating safe pancreatic islet cell transplantation for type 1 diabetes without immunosuppression. Sana Biotechnology ...
ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback